Cargando…
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Oral vitamin K antagonists (VKAs), warfarin, have been in routine clinical use for almost 70 years for various cardiovascular conditions. Direct-Acting Oral Anticoagulants (DOACs) have emerged as competitive alternatives for VKAs to prevent stroke in patients with non-valvular atrial fibrillation (A...
Autores principales: | Abdelnabi, Mahmoud, Benjanuwattra, Juthipong, Okasha, Osama, Almaghraby, Abdallah, Saleh, Yehia, Gerges, Fady |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960500/ https://www.ncbi.nlm.nih.gov/pubmed/35347478 http://dx.doi.org/10.1186/s43044-022-00259-9 |
Ejemplares similares
-
ST-Elevation Myocardial Infarction as a Late Complication of Mild Coronavirus Disease 2019 Infection: A Case Report
por: Abdelnabi, Mahmoud, et al.
Publicado: (2022) -
Accidentally discovered non‐communicating membranous ventricular septal aneurysm in a middle‐aged male patient
por: Abdelnabi, Mahmoud, et al.
Publicado: (2023) -
IVABRADINE EFFECTS ON COVID-19 INDUCED POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
por: Abdelnabi, Mahmoud, et al.
Publicado: (2023) -
CRT-200.05 Correlation Between Left Ventricular Longitudinal Strain and Laboratory Parameters and Clinical Outcomes in Hospitalized COVID-19 Patients
por: Abdelnabi, Mahmoud, et al.
Publicado: (2023) -
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
por: Abdelnabi, Mahmoud, et al.
Publicado: (2020)